Citations (149)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (19)
Indranil Sarkar, Ravendra Garg & Sylvia van Drunen Littel-van den Hurk. (2019) Selection of adjuvants for vaccines targeting specific pathogens. Expert Review of Vaccines 18:5, pages 505-521.
Read now
Read now
Paurvi Shinde, Vinita Bharat, Annabelle Rodriguez-Oquendo, Beiyan Zhou & Anthony T. Vella. (2018) Understanding how combinatorial targeting of TLRs and TNFR family costimulatory members promote enhanced T cell responses. Expert Opinion on Biological Therapy 18:10, pages 1073-1083.
Read now
Read now
Caroline Van Den Ende, Cinzia Marano, Ayla Van Ahee, Eveline M. Bunge & Laurence De Moerlooze. (2017) The immunogenicity and safety of GSK’s recombinant hepatitis B vaccine in adults: a systematic review of 30 years of experience. Expert Review of Vaccines 16:8, pages 811-832.
Read now
Read now
Nathalie Garçon & Alberta Di Pasquale. (2017) From discovery to licensure, the Adjuvant System story. Human Vaccines & Immunotherapeutics 13:1, pages 19-33.
Read now
Read now
Jing Hu, Liying Qiu, Xiaoli Wang, Xiaopeng Zou, Mengji Lu & Jian Yin. (2015) Carbohydrate-based vaccine adjuvants – discovery and development. Expert Opinion on Drug Discovery 10:10, pages 1133-1144.
Read now
Read now
Nelson F Eng, Nitin Bhardwaj, Rebecca Mulligan & Francisco Diaz-Mitoma. (2013) The potential of 1018 ISS adjuvant in hepatitis B vaccines. Human Vaccines & Immunotherapeutics 9:8, pages 1661-1672.
Read now
Read now
Adele Mount, Sandra Koernig, Anabel Silva, Debbie Drane, Eugene Maraskovsky & Adriana Baz Morelli. (2013) Combination of adjuvants: the future of vaccine design. Expert Review of Vaccines 12:7, pages 733-746.
Read now
Read now
Manmohan Singh, Jina Kazzaz, Mildred Ugozzoli, Barbara Baudner, Mariagrazia Pizza, Marzia Giuliani, Lynn D. Hawkins, Gillis Otten & Derek T. O’Hagan. (2012) MF59 oil-in-water emulsion in combination with a synthetic TLR4 agonist (E6020) is a potent adjuvant for a combination Meningococcus vaccine. Human Vaccines & Immunotherapeutics 8:4, pages 486-490.
Read now
Read now
Ke Ouyang, Liqing Chen, Hongxiang Sun, Jing Du & Minghua Shi. (2012) Screening and appraisal for immunological adjuvant-active fractions from Platycodon grandiflorum total saponins. Immunopharmacology and Immunotoxicology 34:1, pages 126-134.
Read now
Read now
Luisa Romanò & Alessandro R Zanetti. (2011) Safety and immunogenicity of a recombinant hepatitis B vaccine manufactured by a modified process in healthy infants. Expert Review of Vaccines 10:9, pages 1261-1264.
Read now
Read now
Nathalie Garçon, Martine Wettendorff & Marcelle Van Mechelen. (2011) Role of AS04 in human papillomavirus vaccine: mode of action and clinical profile. Expert Opinion on Biological Therapy 11:5, pages 667-677.
Read now
Read now
Holly Sanders & Ian M Feavers. (2011) Adjuvant properties of meningococcal outer membrane vesicles and the use of adjuvants in Neisseria meningitidis protein vaccines. Expert Review of Vaccines 10:3, pages 323-334.
Read now
Read now
Bruce Y. Lee & Sarah M. McGlone. (2010) Pricing of new vaccines. Human Vaccines 6:8, pages 619-626.
Read now
Read now
Jiří Beran, Lenka Hobzova, Veronika Wertzova, Sherine Kuriyakose, Maarten Leyssen, Murielle Surquin & Sophie Houard. (2010) Safety and immunogenicity of an investigational adjuvanted hepatitis B vaccine (HB-AS02V) in healthy adults. Human Vaccines 6:7, pages 578-584.
Read now
Read now
Jiri Beran. (2008) Safety and immunogenicity of a new hepatitis B vaccine for the protection of patients with renal insufficiency including pre-haemodialysis and haemodialysis patients. Expert Opinion on Biological Therapy 8:2, pages 235-247.
Read now
Read now
Vikas Jain, Rajnish Sahu, Shailja Misra-Bhattacharya, Suresh Prasad Vyas & Dharmveer Kohli. (2008) Enhancement of T-helper type I immune responses against hepatitis B surface antigen by LPS derivatives adjuvanted liposomes delivery system. Journal of Drug Targeting 16:9, pages 706-715.
Read now
Read now
Zoltan Beck, Nicos Karasavvas, Gary R. Matyas & Carl R. Alving. (2008) Membrane-specific antibodies induced by liposomes can simultaneously bind to HIV-1 protein, peptide, and membrane lipid epitopes. Journal of Drug Targeting 16:7-8, pages 535-542.
Read now
Read now
Nathalie Garçon, Patrick Chomez & Marcelle Van Mechelen. (2007) GlaxoSmithKline Adjuvant Systems in vaccines: concepts, achievements and perspectives. Expert Review of Vaccines 6:5, pages 723-739.
Read now
Read now
Clint S Schmidt, W John W Morrow & Nadeem A Sheikh. (2007) Smart adjuvants. Expert Review of Vaccines 6:3, pages 391-400.
Read now
Read now
Articles from other publishers (130)
Bineet Narayan, Shailendra Kumar Verma, Sandeep Singh, Mahendra K. Gupta & Subodh Kumar. (2023) Protective antigen of Bacillus anthracis in combination with TLR4 or TLR5 agonist confers superior protection against lethal challenge in mouse model. Microbes and Infection 25:8, pages 105183.
Crossref
Crossref
Sara Fernández Sánchez-Escalonilla, Jesus Gonzalez-Rubio, Alberto Najera, Jose Miguel Cantero Escribano, Francisco Jesús Molina Cabrero & Jesús García Guerrero. (2023) Using the AS04C-adjuvanted hepatitis B vaccine in patients classified as non-responders. Transactions of The Royal Society of Tropical Medicine and Hygiene.
Crossref
Crossref
Ming‐Yan Yang, Mei‐Hua Zheng, Xiang‐Ting Meng, Le‐Wei Ma, Hai‐Yue Liang & Hua‐Ying Fan. (2023)
Role of toll‐like receptors in the pathogenesis of
COVID
‐19: Current and future perspectives
. Scandinavian Journal of Immunology 98:2.
Crossref
Crossref
Hongze Ren, Wencong Jia, Yujie Xie, Meihua Yu & Yu Chen. (2023) Adjuvant physiochemistry and advanced nanotechnology for vaccine development. Chemical Society Reviews 52:15, pages 5172-5254.
Crossref
Crossref
Tingmei Zhao, Yulong Cai, Yujie Jiang, Xuemei He, Yuquan Wei, Yifan Yu & Xiaohe Tian. (2023) Vaccine adjuvants: mechanisms and platforms. Signal Transduction and Targeted Therapy 8:1.
Crossref
Crossref
Annalaura Brai, Federica Poggialini, Claudia Pasqualini, Claudia Immacolata Trivisani, Chiara Vagaggini & Elena Dreassi. (2023) Progress towards Adjuvant Development: Focus on Antiviral Therapy. International Journal of Molecular Sciences 24:11, pages 9225.
Crossref
Crossref
Kamel Chettab, Chantel Fitzsimmons, Alexey Novikov, Morgane Denis, Capucine Phelip, Doriane Mathé, Pierre Antoine Choffour, Sabine Beaumel, Eric Fourmaux, Patrick Norca, David Kryza, Anne Evesque, Lars Petter Jordheim, Emeline Perrial, Eva-Laure Matera, Martine Caroff, Jerome Kerzerho & Charles Dumontet. (2023) A systemically administered detoxified TLR4 agonist displays potent antitumor activity and an acceptable tolerance profile in preclinical models. Frontiers in Immunology 14.
Crossref
Crossref
César Reyes & Manuel A. Patarroyo. (2023) Adjuvants approved for human use: What do we know and what do we need to know for designing good adjuvants?. European Journal of Pharmacology 945, pages 175632.
Crossref
Crossref
John W. Ward, Nasamon Wanlapakorn, Yong Poovorawan & Daniel Shouval. 2023. Plotkin's Vaccines. Plotkin's Vaccines
389
432.e21
.
Shubhmita Bhatnagar, Vishnu Revuri, Manan Shah, Peter Larson, Zekun Shao, Daohai Yu, Swayam Prabha, Thomas S. Griffith, David Ferguson & Jayanth Panyam. (2022) Combination of STING and TLR 7/8 Agonists as Vaccine Adjuvants for Cancer Immunotherapy. Cancers 14:24, pages 6091.
Crossref
Crossref
Sachin S. Shivatare, Vidya S. Shivatare & Chi-Huey Wong. (2022) Glycoconjugates: Synthesis, Functional Studies, and Therapeutic Developments. Chemical Reviews 122:20, pages 15603-15671.
Crossref
Crossref
Woojong Lee & M. Suresh. (2022) Vaccine adjuvants to engage the cross-presentation pathway. Frontiers in Immunology 13.
Crossref
Crossref
Jenny E. Hernandez-Davies, Emmanuel P. Dollinger, Egest J. Pone, Jiin Felgner, Li Liang, Shirin Strohmeier, Sharon Jan, Tyler J. Albin, Aarti Jain, Rie Nakajima, Algimantas Jasinskas, Florian Krammer, Aaron Esser-Kahn, Philip L. Felgner, Qing Nie & D. Huw Davies. (2022) Magnitude and breadth of antibody cross-reactivity induced by recombinant influenza hemagglutinin trimer vaccine is enhanced by combination adjuvants. Scientific Reports 12:1.
Crossref
Crossref
Jing-Xing Yang, Jen-Chih Tseng, Guann-Yi Yu, Yunping Luo, Chi-Ying F. Huang, Yi-Ren Hong & Tsung-Hsien Chuang. (2022) Recent Advances in the Development of Toll-like Receptor Agonist-Based Vaccine Adjuvants for Infectious Diseases. Pharmaceutics 14:2, pages 423.
Crossref
Crossref
Farrhana Ziana Firdaus, Mariusz Skwarczynski & Istvan Toth. 2022. Vaccine Design. Vaccine Design
145
178
.
Yen-Ju Lin, Adam Flaczyk, Sonja Wolfheimer, Alexandra Goretzki, Annette Jamin, Andrea Wangorsch, Stefan Vieths, Stephan Scheurer & Stefan Schülke. (2021) The Fusion Protein rFlaA:Betv1 Modulates DC Responses by a p38-MAPK and COX2-Dependent Secretion of PGE2 from Epithelial Cells. Cells 10:12, pages 3415.
Crossref
Crossref
Yucheol Cheong, Minjin Kim, Jina Ahn, Hana Oh, Jongkwan Lim, Wonil Chae, Seung Won Yang, Min Seok Kim, Ji Eun Yu, Sanguine Byun, Yo Han Jang & Baik Lin Seong. (2021) Epigallocatechin-3-Gallate as a Novel Vaccine Adjuvant. Frontiers in Immunology 12.
Crossref
Crossref
Guang Han Ong, Benedict Shi Xiang Lian, Takumi Kawasaki & Taro Kawai. (2021) Exploration of Pattern Recognition Receptor Agonists as Candidate Adjuvants. Frontiers in Cellular and Infection Microbiology 11.
Crossref
Crossref
Leqing Zhu, Zhiwei Lei, Xichun Xia, Yingying Zhang, Yuyuan Chen, Baocheng Wang, Jiawei Li, Guangqiang Li, Guang Yang, Guangchao Cao & Zhinan Yin. (2021)
Yeast Shells Encapsulating Adjuvant AS04 as an Antigen Delivery System for a Novel Vaccine against
Toxoplasma Gondii
. ACS Applied Materials & Interfaces 13:34, pages 40415-40428.
Crossref
Crossref
Anaïs Vallet‐Pichard & Stanislas Pol. (2021) Review article: immunisation against hepatitis B virus infection and the prevention of hepatocellular carcinoma. Alimentary Pharmacology & Therapeutics 53:11, pages 1166-1182.
Crossref
Crossref
Bali Pulendran, Prabhu S. Arunachalam & Derek T. O’Hagan. (2021) Emerging concepts in the science of vaccine adjuvants. Nature Reviews Drug Discovery 20:6, pages 454-475.
Crossref
Crossref
Carlo Pifferi, Roberto Fuentes & Alberto Fernández-Tejada. (2021) Natural and synthetic carbohydrate-based vaccine adjuvants and their mechanisms of action. Nature Reviews Chemistry 5:3, pages 197-216.
Crossref
Crossref
Marina Luchner, Sören Reinke & Anita Milicic. (2021) TLR Agonists as Vaccine Adjuvants Targeting Cancer and Infectious Diseases. Pharmaceutics 13:2, pages 142.
Crossref
Crossref
José L. Bravo-Grande, M. Asunción Blanco-González, José M. de la Torre-Robles, Marita P. Asmat-Inostrosa, Marina Fernández-Escribano, Itria Mirabella Villalobos, M. Covadonga Caso-Pita, Marina Hervella-Ordoñez, Luis M. Cañibano Cimas, José M. de la Fuente-Martín, M. Luisa Rodríguez de la Pinta, Jenry Ricardo Borda Olivas, Carmen Muñóz-Ruipérez, Miguel A. Alonso López, MT del Campo, M. Antonieta Ramírez Pérez, Ignacio Sánchez-Arcilla, Marco Marzola-Payares, Fernando Rescalvo-Santiago, Miguel de Paula-Ortiz, José M. Sánchez-Santos & Ricardo López-Pérez. (2021) Vaccination adjuvated against hepatitis B in Spanish National Healthcare System (SNS) workers typed as non-responders to conventional vaccines. Vaccine 39:3, pages 554-563.
Crossref
Crossref
Dania Zhivaki, Francesco Borriello, Ohn A. Chow, Benjamin Doran, Ira Fleming, Derek J. Theisen, Paris Pallis, Alex K. Shalek, Caroline L. Sokol, Ivan Zanoni & Jonathan C. Kagan. (2020) Inflammasomes within Hyperactive Murine Dendritic Cells Stimulate Long-Lived T Cell-Mediated Anti-tumor Immunity. Cell Reports 33:7, pages 108381.
Crossref
Crossref
Amin Azimi, Sheida Heidarian, Homa Zamani, Nastaran Taleghani, Mohsen Dehghani & Ehsan Seyedjafari. (2020) Optimized dose of synthetic analogues of Monophosphoryl lipid A as an effective alternative for formulating recombinant human papillomavirus vaccine. Biologicals 68, pages 60-64.
Crossref
Crossref
Sahra Bashiri, Prashamsa Koirala, Istvan Toth & Mariusz Skwarczynski. (2020) Carbohydrate Immune Adjuvants in Subunit Vaccines. Pharmaceutics 12:10, pages 965.
Crossref
Crossref
Morgan Brisse, Sophia M. Vrba, Natalie Kirk, Yuying Liang & Hinh Ly. (2020) Emerging Concepts and Technologies in Vaccine Development. Frontiers in Immunology 11.
Crossref
Crossref
Quyen Thi Nguyen, Eunjin Kim, Jihyun Yang, Chankyu Lee, Da Hui Ha, Choon Geun Lee, Ye Ram Lee & Haryoung Poo. (2020) E. coli-Produced Monophosphoryl Lipid a Significantly Enhances Protective Immunity of Pandemic H1N1 Vaccine. Vaccines 8:2, pages 306.
Crossref
Crossref
Daniel Shouval. 2020. Clinical Dilemmas in Viral Liver Disease. Clinical Dilemmas in Viral Liver Disease
169
174
.
Wei Zhang, Li Xu, Hae-Bin Park, Juyoung Hwang, Minseok Kwak, Peter C. W. Lee, Guang Liang, Xiaoyan Zhang, Jianqing Xu & Jun-O Jin. (2020) Escherichia coli adhesion portion FimH functions as an adjuvant for cancer immunotherapy. Nature Communications 11:1.
Crossref
Crossref
Stijn F H Raven, Christian J P A Hoebe, Ann C T M Vossen, Leo G Visser, Jeannine L A Hautvast, Anna H E Roukens & Jim E van Steenbergen. (2020) Serological response to three alternative series of hepatitis B revaccination (Fendrix, Twinrix, and HBVaxPro-40) in healthy non-responders: a multicentre, open-label, randomised, controlled, superiority trial. The Lancet Infectious Diseases 20:1, pages 92-101.
Crossref
Crossref
David H. Mulama, Lorraine Z. Mutsvunguma, Jennifer Totonchy, Peng Ye, Joslyn Foley, Gabriela M. Escalante, Esther Rodriguez, Ramina Nabiee, Murali Muniraju, Felix Wussow, Anne K. Barasa & Javier Gordon Ogembo. (2019) A multivalent Kaposi sarcoma-associated herpesvirus-like particle vaccine capable of eliciting high titers of neutralizing antibodies in immunized rabbits. Vaccine 37:30, pages 4184-4194.
Crossref
Crossref
Aloysious Ssemaganda, Ashwini Kumar Giddam, Mehfuz Zaman, Mariusz Skwarczynski, Istvan Toth, Danielle I. Stanisic & Michael F. Good. (2019) Induction of Plasmodium-Specific Immune Responses Using Liposome-Based Vaccines. Frontiers in Immunology 10.
Crossref
Crossref
Frank Blanco-Pérez, Alexandra Goretzki, Sonja Wolfheimer & Stefan Schülke. (2019) The vaccine adjuvant MPLA activates glycolytic metabolism in mouse mDC by a JNK-dependent activation of mTOR-signaling. Molecular Immunology 106, pages 159-169.
Crossref
Crossref
Yoshifumi Naito, Saeko Hamaoka, Mao Kinoshita, Atsushi Kainuma, Masaru Shimizu, Hideya Katoh, Kiyoshi Moriyama, Ken J. Ishii & Teiji Sawa. (2018)
The protective effects of nasal PcrV‐CpG oligonucleotide vaccination against
Pseudomonas aeruginosa
pneumonia
. Microbiology and Immunology 62:12, pages 774-785.
Crossref
Crossref
Steven G. Reed, Darrick Carter, Corey Casper, Malcolm S. Duthie & Christopher B. Fox. (2018) Correlates of GLA family adjuvants’ activities. Seminars in Immunology 39, pages 22-29.
Crossref
Crossref
Eun-Ju Ko, Youri Lee, Young-Tae Lee, Yu-Jin Kim, Ki-Hye Kim & Sang-Moo Kang. (2018) MPL and CpG combination adjuvants promote homologous and heterosubtypic cross protection of inactivated split influenza virus vaccine. Antiviral Research 156, pages 107-115.
Crossref
Crossref
Zoltan Beck, Oscar B. Torres, Gary R. Matyas, David E. Lanar & Carl R. Alving. (2018) Immune response to antigen adsorbed to aluminum hydroxide particles: Effects of co-adsorption of ALF or ALFQ adjuvant to the aluminum-antigen complex. Journal of Controlled Release 275, pages 12-19.
Crossref
Crossref
Stefan Schülke. (2018) Induction of Interleukin-10 Producing Dendritic Cells As a Tool to Suppress Allergen-Specific T Helper 2 Responses. Frontiers in Immunology 9.
Crossref
Crossref
Faranak Mavandadnejad, Mohammad Hossein Yazdi, Seyed Mehdi Hassanzadeh, Mehdi Mahdavi, Mohammad Ali Faramarzi, Hamidreza Pazoki‐Toroudi & Ahmad Reza Shahverdi. (2017)
Biosynthesis of SeNPs by
Mycobacterium bovis
and their enhancing effect on the immune response against HBs antigens: an
in vivo
study
. IET Nanobiotechnology 12:1, pages 57-63.
Crossref
Crossref
A. V. Kozyr, L. A. Lisitskaya, A. K. Ryabko, N. A. Zeninskaya, M. A. Marin, O. N. Krasavtseva, I. G. Shemyakin & A. V. Kolesnikov. (2018) Shaperone-Dependent Optimization of Expression in E. coli and Purification of Soluble Recombinant Lipid A Phosphatase LpxE from Francisella tularensis. Molecular Genetics, Microbiology and Virology 33:1, pages 34-43.
Crossref
Crossref
A. V. Kozyr, L. A. Lisitskaya, A. K. Ryabko, N. A. Zeninskaya, M. A. Marin, O. N. Krasavtseva, I. G. Shemyakin & A. V. Kolesnikov. (2018) Shaperone-dependent optimization of expression in E.coli and purification of soluble recombinant lipid a phosphatase LpxE from Francisella tularensis. Molecular Genetics Microbiology and Virology (Russian version) 36:1, pages 29.
Crossref
Crossref
Mei-Chin Chen, Kuan-Ying Lai, Ming-Hung Ling & Chun-Wei Lin. (2018) Enhancing immunogenicity of antigens through sustained intradermal delivery using chitosan microneedles with a patch-dissolvable design. Acta Biomaterialia 65, pages 66-75.
Crossref
Crossref
Pierre Van Damme, John W. Ward, Daniel Shouval & Alessandro Zanetti. 2018. Plotkin's Vaccines. Plotkin's Vaccines
342
374.e17
.
L. Abraham-Inpijn. 2018. Het tandheelkundig Jaar 2018. Het tandheelkundig Jaar 2018
281
292
.
Jean-Marc Cavaillon & Mervyn SingerDennis M. Klinman & Hidekazu Shirota. 2017. Inflammation - From Molecular and Cellular Mechanisms to the Clinic. Inflammation - From Molecular and Cellular Mechanisms to the Clinic
143
174
.
T.A. Kuznetsova, L.A. Ivanushko, E.V. Persiyanova, A.L. Shutikova, S.P. Ermakova, M.Yu. Khotimchenko & N.N. Besednova. (2017) Evaluation of adjuvant effects of fucoidane from brown seaweed Fucus evanescens and its structural analogues for the strengthening vaccines effectiveness. Biomeditsinskaya Khimiya 63:6, pages 553-558.
Crossref
Crossref
Wivine Burny, Andrea Callegaro, Viviane Bechtold, Frédéric Clement, Sophie Delhaye, Laurence Fissette, Michel Janssens, Geert Leroux-Roels, Arnaud Marchant, Robert A. van den Berg, Nathalie Garçon, Robbert van der Most & Arnaud M. Didierlaurent. (2017) Different Adjuvants Induce Common Innate Pathways That Are Associated with Enhanced Adaptive Responses against a Model Antigen in Humans. Frontiers in Immunology 8.
Crossref
Crossref
Cecilia H. Marzabadi & Richard W. Franck. (2017) Small-Molecule Carbohydrate-Based Immunostimulants. Chemistry - A European Journal 23:8, pages 1728-1742.
Crossref
Crossref
Eun-Ju KoYoung-Tae LeeYouri LeeKi-Hye KimSang-Moo Kang. (2017) Distinct Effects of Monophosphoryl Lipid A, Oligodeoxynucleotide CpG, and Combination Adjuvants on Modulating Innate and Adaptive Immune Responses to Influenza Vaccination. Immune Network 17:5, pages 326.
Crossref
Crossref
Eun-Ju Ko, Young-Tae Lee, Ki-Hye Kim, Youri Lee, Yu-Jin Jung, Min-Chul Kim, Yu-Na Lee, Taeuk Kang & Sang-Moo Kang. (2017) Roles of Aluminum Hydroxide and Monophosphoryl Lipid A Adjuvants in Overcoming CD4+ T Cell Deficiency To Induce Isotype-Switched IgG Antibody Responses and Protection by T-Dependent Influenza Vaccine. The Journal of Immunology 198:1, pages 279-291.
Crossref
Crossref
Vikram Basava, Heather Romlein, Constantine Bitsaktsis & Cecilia H. Marzabadi. (2017) Synthesis and immunological evaluation of a low molecular weight saccharide with TLR-4 agonist activity. Bioorganic & Medicinal Chemistry 25:2, pages 697-705.
Crossref
Crossref
K.L. Wilson, S.D. Xiang & M. Plebanski. 2017. Micro and Nanotechnology in Vaccine Development. Micro and Nanotechnology in Vaccine Development
99
125
.
Geert Leroux-Roels, Arnaud Marchant, Jack Levy, Pierre Van Damme, Tino F. Schwarz, Yves Horsmans, Wolfgang Jilg, Peter G. Kremsner, Edwige Haelterman, Frédéric Clément, Julian J. Gabor, Meral Esen, Annick Hens, Isabelle Carletti, Laurence Fissette, Fernanda Tavares Da Silva, Wivine Burny, Michel Janssens, Philippe Moris, Arnaud M. Didierlaurent, Robbert Van Der Most, Nathalie Garçon, Pascale Van Belle & Marcelle Van Mechelen. (2016) Impact of adjuvants on CD4+ T cell and B cell responses to a protein antigen vaccine: Results from a phase II, randomized, multicenter trial. Clinical Immunology 169, pages 16-27.
Crossref
Crossref
Gary Brook, Sanjay Bhagani, Ranjababu Kulasegaram, Adele Torkington, David Mutimer, Elizabeth Hodges, Louise Hesketh, Simon Farnworth, Verity Sullivan, Charles Gore, Emma Devitt & Ann K Sullivan. (2016) United Kingdom National Guideline on the Management of the viral hepatitides A, B and C 2015. International Journal of STD & AIDS 27:7, pages 501-525.
Crossref
Crossref
Djin-Ye Oh, David J. Dowling, Saima Ahmed, Hyungwon Choi, Spencer Brightman, Ilana Bergelson, Sebastian T. Berger, John F. Sauld, Matthew Pettengill, Alvin T. Kho, Henry J. Pollack, Hanno Steen & Ofer Levy. (2016) Adjuvant-induced Human Monocyte Secretome Profiles Reveal Adjuvant- and Age-specific Protein Signatures. Molecular & Cellular Proteomics 15:6, pages 1877-1894.
Crossref
Crossref
Sonja T. H. M. Kolanowski, Suzanne N. Lissenberg-Thunnissen, Diba Emal, S. Marieke van Ham & Anja ten Brinke. (2016) Monophosphoryl lipid A-induced pro-inflammatory cytokine expression does not require CD14 in primary human dendritic cells. Inflammation Research 65:6, pages 449-458.
Crossref
Crossref
Stefan Schülke, Lothar Vogel, Ann-Christine Junker, Kay-Martin Hanschmann, Adam Flaczyk, Stefan Vieths & Stephan Scheurer. (2016)
A Fusion Protein Consisting of the Vaccine Adjuvant Monophosphoryl Lipid A and the Allergen Ovalbumin Boosts Allergen-Specific Th1, Th2, and Th17 Responses
In Vitro
. Journal of Immunology Research 2016, pages 1-8.
Crossref
Crossref
Harry B. Greenberg & Philip R. Dormitzer. 2016. Encyclopedia of Immunobiology. Encyclopedia of Immunobiology
389
395
.
Matthias GieseMatthias Giese. 2016. Introduction to Molecular Vaccinology. Introduction to Molecular Vaccinology
145
163
.
Kai Schulze, Thomas Ebensen, Peggy Riese, Blair Prochnow, Claus-Michael Lehr & Carlos A. Guzmán. 2016. How to Overcome the Antibiotic Crisis. How to Overcome the Antibiotic Crisis
207
234
.
S. Schülke, A. Flaczyk, L. Vogel, N. Gaudenzio, I. Angers, B. Löschner, S. Wolfheimer, I. Spreitzer, S. Qureshi, M. Tsai, S. Galli, S. Vieths & S. Scheurer. (2015) MPLA shows attenuated pro-inflammatory properties and diminished capacity to activate mast cells in comparison with LPS. Allergy 70:10, pages 1259-1268.
Crossref
Crossref
Jaswinder Singh Sodhi, Wasim Raja, Showkat Ali Zargar, Abid Showkat, Shaheena Parveen, Syed Nisar, Manzoor Ahmad Wani, Gul Javid, Mushtaq Khan, Sheikh Aejaz, Gul Mohd, Aleem Jan, Gh Nabi Yattoo, Altaf Shah, Gh Mohd Gulzar & Rashid Lone. (2015) The efficacy of accelerated, multiple, double-dose hepatitis B vaccine against hepatitis B virus infection in cancer patients receiving chemotherapy. Indian Journal of Gastroenterology 34:5, pages 372-379.
Crossref
Crossref
Li He, Aiping Zang, Min Du, Dapeng Ma, Chuanping Yuan, Chun Zhou, Jing Mu, Huanjing Shi, Dapeng Li, Xulin Huang, Qiang Deng, Jianhua Xiao, Huimin Yan, Lijian Hui, Ke Lan, Sidong Xiong, Xiaoxia Li, Zhong Huang & Hui Xiao. (2015) mTOR regulates TLR-induced c-fos and Th1 responses to HBV and HCV vaccines. Virologica Sinica 30:3, pages 174-189.
Crossref
Crossref
Xiaoyuan Wang, Peter J. QuinnAixin Yan. (2014)
Kdo
2
‐lipid A: structural diversity and impact on immunopharmacology
. Biological Reviews 90:2, pages 408-427.
Crossref
Crossref
Alberta Pasquale, Scott Preiss, Fernanda Silva & Nathalie Garçon. (2015) Vaccine Adjuvants: from 1920 to 2015 and Beyond. Vaccines 3:2, pages 320-343.
Crossref
Crossref
Geert Leroux-Roels. (2014) Old and new adjuvants for hepatitis B vaccines. Medical Microbiology and Immunology 204:1, pages 69-78.
Crossref
Crossref
Tomer Israely, Sharon Melamed, Hagit Achdout, Noam Erez, Boaz Politi, Trevor Waner, Shlomo Lustig & Nir Paran. (2014) TLR3 and TLR9 Agonists Improve Postexposure Vaccination Efficacy of Live Smallpox Vaccines. PLoS ONE 9:10, pages e110545.
Crossref
Crossref
Franco Giovanetti. (2018) Hepatitis B immunization in patients with chronic renal failure. Giornale di Tecniche Nefrologiche e Dialitiche 26:4, pages 326-328.
Crossref
Crossref
Ozan S. Kumru, Sangeeta B. Joshi, Dawn E. Smith, C. Russell Middaugh, Ted Prusik & David B. Volkin. (2014) Vaccine instability in the cold chain: Mechanisms, analysis and formulation strategies. Biologicals 42:5, pages 237-259.
Crossref
Crossref
Claire M. Buchta & Gail A. Bishop. (2014) Toll-like receptors and B cells: functions and mechanisms. Immunologic Research 59:1-3, pages 12-22.
Crossref
Crossref
Deana Toussi & Paola Massari. (2014) Immune Adjuvant Effect of Molecularly-defined Toll-Like Receptor Ligands. Vaccines 2:2, pages 323-353.
Crossref
Crossref
Ji Eun Han, Seo Ri Wui, Kwang Sung Kim, Yang Je Cho, Wan Je Cho & Na Gyong Lee. (2014) Characterization of the Structure and Immunostimulatory Activity of a Vaccine Adjuvant, De-O-Acylated Lipooligosaccharide. PLoS ONE 9:1, pages e85838.
Crossref
Crossref
Jesús Arenas. 2014. Molecular Vaccines. Molecular Vaccines
527
536
.
Julia K. Bohannon, Antonio Hernandez, Perenlei Enkhbaatar, William L. Adams & Edward R. Sherwood. (2013) The Immunobiology of Toll-Like Receptor 4 Agonists. Shock 40:6, pages 451-462.
Crossref
Crossref
Goizalde Solano-Iturri, María Luisa García-Buey, Sonia Blanco-Sampascual & Ricardo Moreno-Otero. (2013) Afectación hepática inducida por vacuna antihepatitis B. Medicina Clínica 141:11, pages 510-511.
Crossref
Crossref
Inga Szurgot, Ewa Szolajska, David Laurin, Benedicte Lambrecht, Laurence Chaperot, Guy Schoehn & Jadwiga Chroboczek. (2013) Self-adjuvanting influenza candidate vaccine presenting epitopes for cell-mediated immunity on a proteinaceous multivalent nanoplatform. Vaccine 31:40, pages 4338-4346.
Crossref
Crossref
Qiang Zhou, Kejian Zhu & Hao Cheng. (2013) Toll-Like Receptors in Human Papillomavirus Infection. Archivum Immunologiae et Therapiae Experimentalis 61:3, pages 203-215.
Crossref
Crossref
Francesco Peri. (2013) Clustered carbohydrates in synthetic vaccines. Chem. Soc. Rev. 42:11, pages 4543-4556.
Crossref
Crossref
Pierre Van Damme, John Ward, Daniel Shouval, Steven Wiersma & Alessandro Zanetti. 2013. Vaccines. Vaccines
205
234
.
Alan R. Shaw & Mark B. Feinberg. 2013. Clinical Immunology. Clinical Immunology
1095
1121
.
William S. Bowen, Siva K. Gandhapudi, Joseph P. Kolb & Thomas C. Mitchell. 2013. Immunopharmacology. Immunopharmacology
81
128
.
Jeannette Vogt, Frank Stahl, Thomas Scheper & Susann Müller. 2013. Laboratory Protocols in Fungal Biology. Laboratory Protocols in Fungal Biology
265
277
.
Jennifer A Whitaker, Nadine G Rouphael, Srilatha Edupuganti, Lilin Lai & Mark J Mulligan. (2012) Strategies to increase responsiveness to hepatitis B vaccination in adults with HIV-1. The Lancet Infectious Diseases 12:12, pages 966-976.
Crossref
Crossref
Salwa Es-Saad, Nicolas Tremblay, Martin Baril & Daniel Lamarre. (2012) Regulators of innate immunity as novel targets for panviral therapeutics. Current Opinion in Virology 2:5, pages 622-628.
Crossref
Crossref
Andres Mori, Ewa Oleszycka, Fiona A. Sharp, Michelle Coleman, Yuki Ozasa, Manmohan Singh, Derek T. O'Hagan, Lidia Tajber, Owen I. Corrigan, Edel A. McNeela & Ed C. Lavelle. (2012)
The vaccine adjuvant alum inhibits
IL
‐12 by promoting
PI
3 kinase signaling while chitosan does not inhibit
IL
‐12 and enhances
T
h1 and
T
h17 responses
. European Journal of Immunology 42:10, pages 2709-2719.
Crossref
Crossref
Mirjam Kool, Kaat Fierens & Bart N. Lambrecht. (2012) Alum adjuvant: some of the tricks of the oldest adjuvant. Journal of Medical Microbiology 61:7, pages 927-934.
Crossref
Crossref
Mona Hedayat, Kiyoshi Takeda & Nima Rezaei. (2010) Prophylactic and therapeutic implications of toll‐like receptor ligands. Medicinal Research Reviews 32:2, pages 294-325.
Crossref
Crossref
João Gonçalves, Helena Soares, Norman L. Eberhardt, Sarah C. R. Lummis, David R. Soto-Pantoja, David D. Roberts, Umadas Maitra, Romit Majumdar, Arunima Biswas, Avik Choudhuri, Umadas Maitra, Jayalakshmi Krishnan, Sangdun Choi, Shaikh M. Atif, Stephen J. McSorley, Michael T. Greenwood, Aisha Qasim Butt, Sinéad M. Miggin, Felipe Francisco Tuon, Enda Shevlin, Sinéad M. Miggin, Austin Della-Franca, Yuyan Chen, Jennifer Anne Byrne, Dimitra Virla, Christos Tsatsanis, Aristides G. Eliopoulos, Maréne Landström, Reshma Sundar, Eun-Sil Sung, Yong-Sung Kim, Adrienn Angyal, Endre Kiss-Toth & Christian Harteneck. 2012. Encyclopedia of Signaling Molecules. Encyclopedia of Signaling Molecules
1866
1875
.
Thomas W. Cullen, David K. Giles, Lindsey N. Wolf, Chantal Ecobichon, Ivo G. Boneca & M. Stephen Trent. (2011) Helicobacter pylori versus the Host: Remodeling of the Bacterial Outer Membrane Is Required for Survival in the Gastric Mucosa. PLoS Pathogens 7:12, pages e1002454.
Crossref
Crossref
Fiona A. Sharp & Ed C. Lavelle. 2010. Pharmaceutical Sciences Encyclopedia. Pharmaceutical Sciences Encyclopedia
1
14
.
Mona Hedayat, Mihai G Netea & Nima Rezaei. (2011) Targeting of Toll-like receptors: a decade of progress in combating infectious diseases. The Lancet Infectious Diseases 11:9, pages 702-712.
Crossref
Crossref
Aiala Salvador, Manoli Igartua, Rosa Maria Hernández & José Luis Pedraz. (2011) An Overview on the Field of Micro- and Nanotechnologies for Synthetic Peptide-Based Vaccines. Journal of Drug Delivery 2011, pages 1-18.
Crossref
Crossref
Federica Sarti, Glen Perera, Fabian Hintzen, Katerina Kotti, Vassilis Karageorgiou, Olga Kammona, Costas Kiparissides & Andreas Bernkop-Schnürch. (2011) In vivo evidence of oral vaccination with PLGA nanoparticles containing the immunostimulant monophosphoryl lipid A. Biomaterials 32:16, pages 4052-4057.
Crossref
Crossref
Folkert Steinhagen, Takeshi Kinjo, Christian Bode & Dennis M. Klinman. (2011) TLR-based immune adjuvants. Vaccine 29:17, pages 3341-3355.
Crossref
Crossref
Christian L. Tielemans, Jiri Vlasak, Dezider Kosa, Jean-Marie Billiouw, Gert A. Verpooten, Ilona Mezei, Miroslav Ryba, Patrick C. Peeters, Olivier Mat, Michel Y. Jadoul, Vladimir Polakovic, Michel Dhaene, Serge Treille, Sherine O. Kuriyakose, Maarten Leyssen, Sophie A. Houard & Murielle Surquin. (2011) Immunogenicity and safety of an investigational AS02v-adjuvanted hepatitis B vaccine in patients with renal insufficiency who failed to respond or to maintain antibody levels after prior vaccination: Results of two open, randomized, comparative trials. Vaccine 29:6, pages 1159-1166.
Crossref
Crossref
Stefaan De Koker, Bart N. Lambrecht, Monique A. Willart, Yvette van Kooyk, Johan Grooten, Chris Vervaet, Jean Paul Remon & Bruno G. De Geest. (2011) Designing polymeric particles for antigen delivery. Chem. Soc. Rev. 40:1, pages 320-339.
Crossref
Crossref
Lawrence Segal, Owen K. Wilby, Chris R. Willoughby, Stéphane Veenstra & Marguerite Deschamps. (2011) Evaluation of the intramuscular administration of Cervarix™ vaccine on fertility, pre- and post-natal development in rats. Reproductive Toxicology 31:1, pages 111-120.
Crossref
Crossref
Holly J. Corbett, Germain J. P. Fernando, Xianfeng Chen, Ian H. Frazer & Mark A. F. Kendall. (2010) Skin Vaccination against Cervical Cancer Associated Human Papillomavirus with a Novel Micro-Projection Array in a Mouse Model. PLoS ONE 5:10, pages e13460.
Crossref
Crossref
G Brook, V Soriano & C Bergin. (2010) European guideline for the management of hepatitis B and C virus infections, 2010. International Journal of STD & AIDS 21:10, pages 669-678.
Crossref
Crossref
Brian O. Ingram, Ali Masoudi & Christian R. H. Raetz. (2010)
Escherichia coli
Mutants That Synthesize Dephosphorylated Lipid A Molecules
. Biochemistry 49:38, pages 8325-8337.
Crossref
Crossref
William G. Fusco, Galyna Afonina, Igor Nepluev, Deborah M. Cholon, Neelima Choudhary, Patricia A. Routh, Glenn W. Almond, Paul E. Orndorff, Herman Staats, Marcia M. Hobbs, Isabelle Leduc & Christopher Elkins. (2010)
Immunization with the
Haemophilus ducreyi
Hemoglobin Receptor HgbA with Adjuvant Monophosphoryl Lipid A Protects Swine from a Homologous but Not a Heterologous Challenge
. Infection and Immunity 78:9, pages 3763-3772.
Crossref
Crossref
Geert Leroux-Roels. (2010) Unmet needs in modern vaccinology. Vaccine 28, pages C25-C36.
Crossref
Crossref
Ping Zhou, Eleonora Altman, Malcolm B. Perry & Jianjun Li. (2010) Study of Matrix Additives for Sensitive Analysis of Lipid A by Matrix-Assisted Laser Desorption Ionization Mass Spectrometry. Applied and Environmental Microbiology 76:11, pages 3437-3443.
Crossref
Crossref
Murielle Surquin, Christian L. Tielemans, Imre Kulcsár, Miroslav Ryba, Péter Vörös, Olivier Mat, Serge Treille, Michel Dhaene, Jean-Claude Stolear, Sherine O. Kuriyakose, Maarten X. Leyssen & Sophie A. Houard. (2010) Rapid, enhanced, and persistent protection of patients with renal insufficiency by AS02V-adjuvanted hepatitis B vaccine. Kidney International 77:3, pages 247-255.
Crossref
Crossref
Richard Brunner, Erika Jensen-Jarolim & Isabella Pali-Schöll. (2010) The ABC of clinical and experimental adjuvants—A brief overview. Immunology Letters 128:1, pages 29-35.
Crossref
Crossref
Arnaud M. Didierlaurent, Sandra Morel, Laurence Lockman, Sandra L. Giannini, Michel Bisteau, Harald Carlsen, Anders Kielland, Olivier Vosters, Nathalie Vanderheyde, Francesca Schiavetti, Daniel Larocque, Marcelle Van Mechelen & Nathalie Garçon. (2009) AS04, an Aluminum Salt- and TLR4 Agonist-Based Adjuvant System, Induces a Transient Localized Innate Immune Response Leading to Enhanced Adaptive Immunity. The Journal of Immunology 183:10, pages 6186-6197.
Crossref
Crossref
Tino F. Schwarz. (2009) Clinical update of the AS04-Adjuvanted human Papillomavirus-16/18 cervical cancer vaccine, cervarix®. Advances in Therapy 26:11, pages 983-998.
Crossref
Crossref
Constance M. John, Mingfeng Liu & Gary A. Jarvis. (2009) Natural Phosphoryl and Acyl Variants of Lipid A from Neisseria meningitidis Strain 89I Differentially Induce Tumor Necrosis Factor-α in Human Monocytes. Journal of Biological Chemistry 284:32, pages 21515-21525.
Crossref
Crossref
Heiner Wedemeyer, Elisabeth Schuller, Verena Schlaphoff, Rudolf E. Stauber, Johannes Wiegand, Ingolf Schiefke, Christa Firbas, Bernd Jilma, Mark Thursz, Stefan Zeuzem, Wolf P. Hofmann, Holger Hinrichsen, Erich Tauber, Michael P. Manns & Christoph S. Klade. (2009) Therapeutic vaccine IC41 as late add-on to standard treatment in patients with chronic hepatitis C. Vaccine 27:37, pages 5142-5151.
Crossref
Crossref
E G Rhee & D H Barouch. (2009) Translational Mini-Review Series on Vaccines for HIV: Harnessing innate immunity for HIV vaccine development. Clinical and Experimental Immunology 157:2, pages 174-180.
Crossref
Crossref
Wagner Quintilio, Flavia S. Kubrusly, Dmitri Iourtov, Cosue Miyaki, Maria Aparecida Sakauchi, Fernanda Lúcio, Sandra de Cássia Dias, Celia S. Takata, Eliane N. Miyaji, Hisako G. Higashi, Luciana C.C. Leite & Isaias Raw. (2009) Bordetella pertussis monophosphoryl lipid A as adjuvant for inactivated split virion influenza vaccine in mice. Vaccine 27:31, pages 4219-4224.
Crossref
Crossref
Barbara C. Baudner, Vanessa Ronconi, Daniele Casini, Marco Tortoli, Jina Kazzaz, Manmohan Singh, Lynn D. Hawkins, Andreas Wack & Derek T. O’Hagan. (2009) MF59 Emulsion Is an Effective Delivery System for a Synthetic TLR4 Agonist (E6020). Pharmaceutical Research 26:6, pages 1477-1485.
Crossref
Crossref
Ding-Shinn Chen. (2009) Hepatitis B vaccination: The key towards elimination and eradication of hepatitis B. Journal of Hepatology 50:4, pages 805-816.
Crossref
Crossref
Lysann Schädlich, Tilo Senger, Carsten J. Kirschning, Martin Müller & Lutz Gissmann. (2009) Refining HPV 16 L1 purification from E. coli: Reducing endotoxin contaminations and their impact on immunogenicity. Vaccine 27:10, pages 1511-1522.
Crossref
Crossref
Thomas Ebensen & Carlos A. Guzmán. 2009. Pharmaceutical Biotechnology. Pharmaceutical Biotechnology
171
188
.
Thomas Verstraeten, Dominique Descamps, Marie-Pierre David, Toufik Zahaf, Karin Hardt, Patricia Izurieta, Gary Dubin & Thomas Breuer. (2008) Analysis of adverse events of potential autoimmune aetiology in a large integrated safety database of AS04 adjuvanted vaccines. Vaccine 26:51, pages 6630-6638.
Crossref
Crossref
Eric M. Bachelder, Tristan T. Beaudette, Kyle E. Broaders, Sergey E. Paramonov, Jesse Dashe & Jean M. J. Fréchet. (2008) Acid-Degradable Polyurethane Particles for Protein-Based Vaccines: Biological Evaluation and in Vitro Analysis of Particle Degradation Products. Molecular Pharmaceutics 5:5, pages 876-884.
Crossref
Crossref
Christina L. Airhart, Harold N. Rohde, Carolyn J. Hovde, Gregory A. Bohach, Claudia F. Deobald, Stephen S. Lee & Scott A. Minnich. (2008) Lipid A mimetics are potent adjuvants for an intranasal pneumonic plague vaccine. Vaccine 26:44, pages 5554-5561.
Crossref
Crossref
Tino F. Schwarz & Oberdan Leo. (2008) Immune response to human papillomavirus after prophylactic vaccination with AS04-adjuvanted HPV-16/18 vaccine: Improving upon nature. Gynecologic Oncology 110:3, pages S1-S10.
Crossref
Crossref
Samar Hamdy, Ommoleila Molavi, Zengshuan Ma, Azita Haddadi, Aws Alshamsan, Zahra Gobti, Sara Elhasi, John Samuel & Afsaneh Lavasanifar. (2008) Co-delivery of cancer-associated antigen and Toll-like receptor 4 ligand in PLGA nanoparticles induces potent CD8+ T cell-mediated anti-tumor immunity. Vaccine 26:39, pages 5046-5057.
Crossref
Crossref
Mary Pao, Esperanza B. Papadopoulos, Joanne Chou, Heller Glenn, Hugo Castro-Malaspina, Ann A. Jakubowski, Nancy A. Kernan, Miguel A. Perales, Susan Prokop, Andromachi Scaradavou, Marcel R. vanDenBrink, James W. Young, Richard J. O'Reilly & Trudy N. Small. (2008) Response to Pneumococcal (PNCRM7) and Haemophilus Influenzae Conjugate Vaccines (HIB) in Pediatric and Adult Recipients of an Allogeneic Hematopoietic Cell Transplantation (alloHCT). Biology of Blood and Marrow Transplantation 14:9, pages 1022-1030.
Crossref
Crossref
Hua Shen, Bethany M. Tesar, Wendy E. Walker & Daniel R. Goldstein. (2008) Dual Signaling of MyD88 and TRIF Is Critical for Maximal TLR4-Induced Dendritic Cell Maturation. The Journal of Immunology 181:3, pages 1849-1858.
Crossref
Crossref
Carl R. Alving & Mangala Rao. (2008) Lipid A and liposomes containing lipid A as antigens and adjuvants. Vaccine 26:24, pages 3036-3045.
Crossref
Crossref
Edmond J. Remarque, Bart W. Faber, Clemens H.M. Kocken & Alan W. Thomas. (2008) Apical membrane antigen 1: a malaria vaccine candidate in review. Trends in Parasitology 24:2, pages 74-84.
Crossref
Crossref
Alan R. Shaw & Mark B. Feinberg. 2008. Clinical Immunology. Clinical Immunology
1353
1382
.
Ian H. Frazer, Doug R. Lowy & John T. Schiller. (2007) Prevention of cancer through immunization: Prospects and challenges for the 21st century. European Journal of Immunology 37:S1, pages S148-S155.
Crossref
Crossref
Marcin Kwissa, Rama R. Amara, Harriet L. Robinson, Bernard Moss, Sefik Alkan, Abdul Jabbar, Francois Villinger & Bali Pulendran. (2007) Adjuvanting a DNA vaccine with a TLR9 ligand plus Flt3 ligand results in enhanced cellular immunity against the simian immunodeficiency virus. The Journal of Experimental Medicine 204:11, pages 2733-2746.
Crossref
Crossref
Allison ChamberlainGigi Kwik Gronvall. (2007) Immune-Boosting Adjuvants. Biosecurity and Bioterrorism: Biodefense Strategy, Practice, and Science 5:3, pages 202-205.
Crossref
Crossref